Stocklytics Platform
Asset logo for symbol AMGN
Amgen
AMGN72
$275.78arrow_drop_down0.52%-$1.45
S&P500
Asset logo for symbol AMGN
AMGN72

$275.78

arrow_drop_down0.52%

Performance History

Chart placeholder
Key Stats
Open$277.86
Prev. Close$277.63
EPS7.82
Next Earnings DateMar 13, 2025
LOWHIGH
Day Range272.31
277.83
52 Week Range249.70
346.85
Ratios
EPS7.82

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Amgen (AMGN)

Amgen Inc (AMGN) is a renowned biotechnology company that specializes in the development, manufacturing, and marketing of innovative human therapeutics. With a strong commitment to improving patient's lives, Amgen has established itself as a leader in the biopharmaceutical industry.
Having a solid track record, Amgen has consistently delivered impressive financial performance. The company's stock price history reflects its success and growth over the years. Investors have witnessed steady returns, which have made Amgen a popular choice among long-term investors.
Sector
Healthcare
Industry
Drug Manufacturers—General
CEO
Mr. Robert A. Bradway
Headquarters
Thousand Oaks
Employees
25200
Exchange
NASDAQ
add Amgen  to watchlist

Keep an eye on Amgen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for Amgen (AMGN)?

For Amgen (AMGN), the 52-week high is $346.85, which is 25.77% from the current price. The 52-week low is $249.7, the current price is 10.45% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

What is Amgen 's (AMGN) price per share?

The current price per share for Amgen (AMGN) is $275.79. The stock has seen a price change of -$1.46 recently, indicating a -0.53% change. This reflects the stock's recent market performance and investor sentiment.
help

Is Amgen (AMGN) a growth stock?

Amgen (AMGN) has shown an average price growth of -2.59% over the past three years. It has received a score of 61 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Amgen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Amgen (AMGN) stock price performance year to date (YTD)?

As of the latest data, Amgen (AMGN) has a year-to-date price change of -7.26%. Over the past month, the stock has experienced a price change of -14.3%. Over the last three months, the change has been -15.38%. Over the past six months, the figure is -9.49%. Looking at a longer horizon, the five-year price change stands at 18.46%.
help

Is Amgen (AMGN) a profitable company?

Amgen (AMGN) has a net income of $6.72B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 70.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 24.16% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $28.19B, with a revenue growth rate of 7.09%, providing insight into the company's sales performance and growth. The gross profit is $19.74B. Operating income is noted at $7.9B. Furthermore, the EBITDA is $13.48B.
help

What is the market capitalization of Amgen (AMGN)?

Amgen (AMGN) has a market capitalization of $149.16B. The average daily trading volume is 276, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level